Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

487.31 +6.30 (+1.31%)
Streaming Delayed Price Updated: 10:08 AM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 68,543
Open 479.20
Bid (Size) 487.17 (160)
Ask (Size) 487.45 (280)
Prev. Close 481.01
Today's Range 479.00 - 487.96
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Ultimate Biotech Stock to Buy With $500 Right Now ↗
This biotech powerhouse could maintain its strength for the long term. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036? ↗
Even a great stock has a ceiling. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+7.8%
+7.8%
1 Month
+2.2%
+2.2%
3 Month
+14.9%
+14.9%
6 Month
+25.3%
+25.3%
1 Year
+1.2%
+1.2%

More News

Read More
News headline image
The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices ↗
Via The Motley Fool
Topics ETFs
News headline image
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗
Via MarketBeat
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Posts Mixed Q4 2025 Results, Provides 2026 Guidance ↗
Via Chartmill
News headline image
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q4 Earnings Call
Via StockStory
Topics Earnings
News headline image
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
Via StockStory
Topics Stocks
News headline image
Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
Via Finterra
Topics Economy Intellectual Property
News headline image
Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom
Via MarketMinute
News headline image
Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy
News headline image
The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026 ↗
Via The Motley Fool
Top S&P500 movers in Friday's session ↗
Via Chartmill
News headline image
Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss) ↗
Via The Motley Fool
Friday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
Via MarketMinute
Topics Artificial Intelligence ETFs Government
News headline image
VRTX Q4 Deep Dive: Diversification Beyond Cystic Fibrosis Sets Stage for Next Growth Phase
Via StockStory
News headline image
Vertex (VRTX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue
Via StockStory
News headline image
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Buy Vertex Before Feb. 12? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Provident Dumps 490,000 MapleBear Shares Worth $18 Million ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 487.31
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 02/24/26 10:08 AM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 126.42B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 126B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.